BLB&B Advisors’s Bio-Techne TECH Stock Holding History

BLB&B Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,220	Closed	-$269K	–	270
2021 Q3	$269K	Buy	+2,220	New	+$270K	0.02%	239

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

BLB&B Advisors's TECH Position: Q4 2021 in Review

BLB&B Advisors sold out of Bio-Techne (TECH) in Q4 2021, closing a stake of 2,220 shares — an estimated $269K sold.

BLB&B Advisors first reported a position in TECH in Q3 2021 and held it in 1 quarter. The position peaked at $269K in Q3 2021. 575 funds tracked by Wall St. Rank hold TECH as of Q4 2021.

BLB&B Advisors reported no remaining Bio-Techne position as of Q4 2021 after selling out during the quarter.
BLB&B Advisors sold 2,220 Bio-Techne shares in Q4 2021, an estimated $269K.
BLB&B Advisors first reported a position in Bio-Techne in Q3 2021 and held it in 1 quarter.
BLB&B Advisors's Bio-Techne position peaked at $269K in Q3 2021.
575 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2021.

Based on BLB&B Advisors's 13F filing for Q4 2021, filed 21 Jan 2022.